SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Alliance Pharmaceutical
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Robert C. Petersen who wrote (331)2/1/1999 11:55:00 AM
From: Cacaito   of 548
 
Fast track does not mean fast development, once development is completed
then the NDA (new drug application) is considered fast track, and this is
approval in 6 months from NDA application acceptance (another two months)

Liquivent is planned for 18 months to complete trial
faster/slower depending on recruitment of subjects. Patients get sick
on their own.

2 months for NDA application acceptance.

6 months for fast track approval.

include some time for preparation of NDA ( 3 months)

and some labeling fights for another 3 months. Most companies get
stuck in the labeling process.

By the time is completed and ready to ship, the stock will be $15 to $30.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News